Chemed Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 18.17%

Chemed Corporation EBITDA Margin is 18.17% for the Trailing 12 Months (TTM) ending March 31, 2025, a 0.41% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Chemed Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 18.09%, a 2.82% change year over year.
  • Chemed Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 17.60%, a -9.59% change year over year.
  • Chemed Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 19.46%, a -14.13% change year over year.
  • Chemed Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 22.67%, a 35.62% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin